E-LIB Suche - Ergebnisse für: Eberhardt, W. E. E.

1

212P Correlation of 68Ga-SSO120 PET with SSTR2 expression a..:

Mavroeidi, I. ; Kersting, D.M. ; Romanowicz, A....
ESMO Open. 9 (2024) - p. 102785 , 2024

Link: https://doi.org/10.1016/..

2

MA21.09 More Accurate Staging of Stage IV Lung Cancer Throu..:

Oezkan, F. ; Hautzel, H. ; Seweryn, M....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S180 , 2023

Link: https://doi.org/10.1016/..

3

EP04.02-005 First Comprehensive Lung Cancer Long-Term Survi..:

Exner, J.-P.H. ; Nadjm, S. ; Hepp de los Rios, R....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S262 , 2022

Link: https://doi.org/10.1016/..

4

MA06.08 Long-term Survival and Competing Risks of Death in ..:

Eberhardt, W.E.E. ; Poettgen, C. ; Gauler, T.C....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S65 , 2022

Link: https://doi.org/10.1016/..

5

EP04.02-007 First Comprehensive Lung Cancer Long-Term Survi..:

Nadjm, S. ; Exner, J.-P.H. ; Hepp De Los Rios, R....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S263 , 2022

Link: https://doi.org/10.1016/..

6

Prospektiv-randomisierte Phase-II-Studie zur Induktionschem..:

Eberhardt, W. E. E. ; Aigner, C. ; Darwiche, K..
Forum. 37 (2022) 1 - p. 62-64 , 2022

Link: https://doi.org/10.1007/..

7

EP04.01-016 First Comprehensive Lung Cancer Long-Term Survi..:

Exner, J.-P. ; Nadjm, S. ; Hepp de los Rios, R....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S252-S253 , 2022

Link: https://doi.org/10.1016/..

8

Die aktuelle Therapie des asbestassoziierten malignen Pleur..:

Aigner, C. ; Brüning, T. ; Eberhardt, W. E. E....
Pneumologie. 75 (2021) 10 - p. 776-794 , 2021

Link: https://doi.org/10.1055/..

9

OC-0493: Pretreatment metabolic volume in PET: Prognostic i..:

Guberina, M. ; Eberhardt, W.E.E. ; Stuschke, M....
Radiotherapy and Oncology. 127 (2018) - p. S253-S254 , 2018

Link: https://doi.org/10.1016/..

10

Immunonkologie: Die sanfte Revolution der Krebsmedizin?:

Schmidberger, H. ; Heiss, M. ; Eberhardt, W. E. E.
Der Onkologe. 23 (2017) 10 - p. 790-792 , 2017

Link: https://doi.org/10.1007/..

11

SELECT-2: a phase II, double-blind, randomized, placebo-con..:

Soria, J.-C. ; Fülöp, A. ; Maciel, C....
Annals of Oncology. 28 (2017) 12 - p. 3028-3036 , 2017

Link: https://doi.org/10.1093/..

12

Comparative efficacy and safety of nivolumab (nivo) vs rele..:

Eberhardt, W.E.E. ; Vanderpuye-Orgle, J. ; Reck, M....
European Journal of Cancer. 72 (2017) - p. S136 , 2017

Link: https://doi.org/10.1016/..

13

16LBA Phase II, single-arm trial (BIRCH) of atezolizumab as..:

Besse, B. ; Johnson, M. ; Janne, P.A....
European Journal of Cancer. 51 (2015) - p. S717-S718 , 2015

Link: https://doi.org/10.1016/..

14

Final results from the large sunitinib global expanded-acce..:

Gore, M E ; Szczylik, C ; Porta, C...
British Journal of Cancer. 113 (2015) 1 - p. 12-19 , 2015

Link: https://doi.org/10.1038/..

15

Adjuvant Erlotinib (E) Versus Placebo (P) for Completely Re..:

Altorki, N.K. ; O'brien, M.E.R. ; Eberhardt, W.E.E....
International Journal of Radiation Oncology*Biology*Physics. 90 (2014) 5 - p. S2-S3 , 2014

Link: https://doi.org/10.1016/..